CDC Vaccine Advisory Panel Recommends Merck’s RSV Shot For Infants Despite Safety Concerns

By Danielle

In a controversial decision, the Advisory Committee on Immunization Practices (ACIP) voted on Thursday to recommend Merck’s monoclonal antibody shot against respiratory syncytial virus (RSV) for infants up to one year of age.

The panel, which advises the Centers for Disease Control and Prevention (CDC) on the vaccine schedule, held its first meeting since Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. retired prior members.

HHS Secretary Robert F. Kennedy Jr. Appoints Robert Malone, Others To Vaccine Advisory Panel

The committee voted 5-2 to recommend the use of Merck’s shot.